Loading organizations...
§ Private Profile · Pembroke Dock, Pembrokeshire, United Kingdom
Biomaterials developer manufacturing medical-grade Collagen Type 0 from jellyfish for tissue engineering, regenerative medicine, and research.
Jellagen, based in Cardiff, Wales, United Kingdom, develops and manufactures medical-grade collagen derived from jellyfish for applications in tissue engineering, regenerative medicine, and scientific research. The company produces Collagen Type 0 as an innovative biomaterial platform, positioning it as a safer alternative to existing collagen sources from mammals and fish. Jellagen operates a 10,000 square-foot ISO13485:2016 certified manufacturing facility, marketing its products for research applications while developing clinical-grade therapeutic formulations. The firm closed an £8.7 million Series A funding round in December 2022, backed by Thai Union Group PCL and existing shareholders. This round brought its total funding to approximately £10.7 million, including £2 million from prior grants and angel investors. Jellagen was founded in 2013 by Andrew Mearns-Spragg.
Jellagen has raised $20.3M across 4 funding rounds.
Jellagen has raised $20.3M in total across 4 funding rounds.
Jellagen has raised $20.3M across 4 funding rounds. Most recently, it raised $10.6M Series A in December 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 8, 2022 | $10.6M Series A | Cardiff Capital Region, Development Bank OF Wales, Thai Union | — | Announced |
| Jun 25, 2020 | $2.4M Seed | — | — | Announced |
| May 11, 2018 | $5.1M Venture Round | Development Bank OF Wales, Newable Ventures | — | Announced |
| Apr 6, 2016 | $2.2M Venture Round | Thomas Paul Descamps, Angels IN Medcity Program | Angels Invest Wales, Xfund | Announced |
Jellagen has raised $20.3M in total across 4 funding rounds.
Jellagen's investors include Cardiff Capital Region, Development Bank of Wales, Thai Union, Newable Ventures, Thomas-Paul Descamps, Angels Invest Wales, Xfund.